Patents by Inventor Janis Vasilevskis
Janis Vasilevskis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6288224Abstract: Aziridines may be subjeted to a cyclooligomerization reaction to produce polyazacycloalkane compounds useful for example in the preparation of chelating agents for use in diagnostic imaging contrast agents. N-benzyl-aziridine in particular is useful as it can be cyclotetramerized and debenzylated to yield cyclen, a key intermediate in chelating agent preparation. The invention provides a particularly attractive route to production of N-benzyl and other N-arylmethyl aziridines of formula (I) where each R1 is independently hydrogen or a group AR and Ar is an optionally substituted phenyl group. The process comprises reacting a purified N-arylmethylethanolamine-sulphonate sulphonate ester with a base. N-aryimethyl-ethanolamine sulphonate ester of the formula R′NHCH2CH2OSO3H, wherein the N-arylmethyl group R′ is an N-(bisarylmethyl) or N-(triarylmethyl) group, as intermediates.Type: GrantFiled: April 10, 2000Date of Patent: September 11, 2001Assignees: Nycomed Salutar, Inc., University of Iowa Research FoundationInventors: Janis Vasilevskis, John Varadarajan, Martha Garrity, Jere Douglas Fellmann, Louis Messerle, Gandara Amarasinghe
-
Patent number: 6153771Abstract: 5-Substituted isophthalic acid bis(allylamides) and bis(allylamide epoxides) in which said 5-substituent is --NO.sub.2, --NH.sub.2, --NHR.sup.1 or --NR.sup.1 R.sup.2 where R.sup.1 and R.sup.2 are independently optionally substituted alkyl, alkenyl, acyl, aryl, aralkyl or alkaryl groups.Type: GrantFiled: September 30, 1998Date of Patent: November 28, 2000Assignee: Nycomed Imaging ASInventors: David Redick Lane, Janis Vasilevskis
-
Patent number: 6048979Abstract: Aziridines may be subjected to a cyclooligomerization reaction to produce polyazacycloalkane compounds useful for example in the preparation of chelating agents for use in diagnostic imaging contrast agents. N-benzyl-aziridine in particular is useful as it can be cyclotetramerized and debenzylated to yield cyclen, a key intermediate in chelating agent preparation. The invention provides a particularly attractive route to production of N-benzyl and other N-arylmethyl aziridines of formula (I) where each R.sub.1 is independently hydrogen or a group AR and Ar is an optionally substituted phenyl group. The process comprises reacting a purified N-arylmethylethanolaminesulphonate ester with a base. N-arylmethyl-ethanolamine sulphonate ester of the formula R'NHCH.sub.2 CH.sub.2 OSO.sub.3 H, wherein the N-arylmethyl group R' is an N-(bisarylmethyl) or N-(triarylmethyl) group, as intermediates. In a further aspect, the invention provides compounds of formula (II) ##STR1## where Ar and R.sub.Type: GrantFiled: December 2, 1997Date of Patent: April 11, 2000Assignees: Nycomed Salutar, Inc., University of Iowa FoundationInventors: Janis Vasilevskis, John Varadarajan, Martha Garrity, Jere Douglas Fellmann, Louis Messerle, Gandara Amarasinghe
-
Patent number: 5824821Abstract: The invention provides a process for the production of a 2,3-dihydroxypropylamino compound, said process comprising the reaction steps of:(i) obtaining an allylamino compound;(ii) epoxidizing said allylamino compound to yield an epoxypropylamino compound; and(iii) hydrolysing said epoxypropylamino compound to yield a 2,3-dihydroxypropylamino compound.This process may be used to produce simple 2,3-dihydroxypropylamino compounds such as APD or complex ones such as BAPD (an intermediate in the production of iohexol).Type: GrantFiled: February 7, 1997Date of Patent: October 20, 1998Assignee: Nycomed Imaging ASInventors: David Redick Lane, Janis Vasilevskis
-
Patent number: 5589595Abstract: The present invention provides a synthetic route for tetraazacycloalkane preparation which facilitates heteropoly-N-alkylation of the macrocyclic product, and is thereby beneficial for the production of chelating agents and chelates useful in diagnostic imaging. The process involves (i) reacting a tetraazaalkane with a bridging agent to couple four amine nitrogens of said tetraazaalkane to a bridging moiety to yield a fused tricyclic intermediate, (ii) reacting said intermediate to introduce an alkylene bridge between the secondary amine nitrogens in the outer rings of the fused tricyclic intermediate, optionally by decoupling an alkanediylidene bridging moiety from the tertiary amine nitrogens at the ring fusion sites of the fused tricyclic intermediate, and (iii) where necessary, decoupling said bridging moiety to yield a macrocyclic tetraazacycloalkane.Type: GrantFiled: June 7, 1995Date of Patent: December 31, 1996Assignee: Nycomed Imaging ASInventors: Rolf W. Sandnes, Kjell Undheim, Michel Gacek, Janis Vasilevskis
-
Patent number: 5376353Abstract: This invention is a process for the production of H.sub.2 O.sub.2 using fullerene. The process involves the hydrogenation of the fullerenes and the reaction of the hydrogenated fullerenes with O.sub.2 to produce H.sub.2 O.sub.2. Preferably the process utilizes a two-phase reaction mixture of a solvent and water. The solvent solvates the fullerenes and any applicable hydrogenation catalyst. The H.sub.2 O.sub.2 is extracted into the water phase for removal from the process.Type: GrantFiled: June 25, 1993Date of Patent: December 27, 1994Inventor: Janis Vasilevskis
-
Patent number: 4853357Abstract: The additional of redox-active metal components and ligands, alternatively or simultaneously, results in increased conversion and selectivity in the palladium-catalyzed oxidation of olefins to carbonyl products in the presence of polyoxoanions. In preferred modes, heteropolyoxoanions and Isopolyoxoanions containing tungsten, molybdenum and vanadium, individually or in combination, are described. The use of copper as the redox-active metal component shows reduced allylic reactivity. The elimination of chloride from the catalyst system provides substantial engineering advantages over the prior art, particularly, the reduction of corrosion and chloro-organic by-product formation. The use of redox-active metal components and/or ligands makes the palladium-polyoxoanion catalyst system industrially practicable.Type: GrantFiled: September 30, 1987Date of Patent: August 1, 1989Assignee: Catalytica AssociatesInventors: Janis Vasilevskis, Jacques C. De Deken, Robert J. Saxton, Paul R. Wentrcek, Jere D. Fellmann, Lyubov S. Kipnis
-
Patent number: 4847421Abstract: A substantially chloride-free palladium oxidation system, comprising a palladium component, a copper component, and a ligand is described. The Wacker system, consisting of palladium and copper chlorides is also improved by the addition of a ligand. The palladium and copper counterion are independently selected from BF.sub.4.sup.--, CF.sub.3 COO.sup.--, CH.sub.3 COO.sup.--, SO.sub.4.sup..dbd., and NO.sub.3.sup.--. The ligand is preferably a nitrile-containing compound.Type: GrantFiled: January 29, 1988Date of Patent: July 11, 1989Assignee: Catalytica, AssociatesInventors: Janis Vasilevskis, Paul L. Ridgway, Eric R. Evitt
-
Patent number: 4738943Abstract: A substantially chloride-free palladium oxidation system, comprising a palladium component, a copper component, and a ligand is described. The Wacker system, consisting of palladium and copper chlorides is also improved by the addition of a ligand. The palladium and copper counterion are independently selected from BF.sub.4.sup.-, CF.sub.3 COO.sup.-, SO.sub.4.sup.=, and NO.sub.3.sup.-. The ligand is preferably a nitrile-containing compound.Type: GrantFiled: August 21, 1987Date of Patent: April 19, 1988Assignee: Catalytica AssociatesInventors: Janis Vasilevskis, Paul L. Ridgway, Eric R. Evitt
-
Patent number: 4723041Abstract: The addition of redox-active metal components and ligands, alternatively or simultaneously, results in increased conversion and selectivity in the palladium-catalyzed oxidation of olefins to carbonyl products in the presence of polyoxoanions. In preferred modes, heteropolyoxoanions and isopolyoxoanions containing tungsten, molybdenum and vanadium, individually or in combination, are described. The use of copper as the redox-active metal component shows reduced allylic reactivity. The elimination of chloride from the catalyst system provides substantial engineering advantages over the prior art, particularly, the reduction of corrosion and chloro-organic by-product formation. The use of redox-active metal components and/or ligands makes the palladium-polyoxoanion catalyst system industrially practicable.Type: GrantFiled: March 31, 1986Date of Patent: February 2, 1988Assignee: Catalytica AssociatesInventors: Janis Vasilevskis, Jacques C. De Deken, Robert J. Saxton, Paul R. Wentrcek, Jere D. Fellmann, Lyubov S. Kipnis
-
Patent number: 4720474Abstract: The addition of redox-active metal components and ligands, alternatively or simultaneously, results in increased conversion and selectivity in the palladium-catalyzed oxidation of olefins to carbonyl products in the presence of polyoxoanions. In preferred modes, heteropolyoxoanions and isopolyoxoanions containing tungsten, molybdenum and vanadium, individually or in combination, are described. The use of copper as the redox-active metal component shows reduced allylic reactivity. The elimination of chloride from the catalyst system provides substantial engineering advantages over the prior art, particularly, the reduction of corrosion and chloro-organic by-product formation. The use of redox-active metal components and/or ligands makes the palladium-polyoxoanion catalyst system industrially practicable.Type: GrantFiled: September 24, 1985Date of Patent: January 19, 1988Assignee: Catalytica AssociatesInventors: Janis Vasilevskis, Jacques C. De Deken, Robert J. Saxton, Paul R. Wentrcek, Jere D. Fellmann, Lyubov S. Kipnis
-
Patent number: 4130712Abstract: A procedure for the synthesis of biotin is disclosed whereby unsaturated diacylated biotin precursors are catalytically hydrogenated with the substantial absence of sulfur poisoning. The hydrogenation procedure dislcosed herein results in optically pure biotin.Type: GrantFiled: June 17, 1977Date of Patent: December 19, 1978Assignee: Hoffmann-La Roche Inc.Inventor: Janis Vasilevskis
-
Patent number: 3977981Abstract: Corrosion of corrodible metal material is prevented by contacting the material with an effective amount of a macrocyclic tetramine.Type: GrantFiled: November 14, 1975Date of Patent: August 31, 1976Assignee: Shell Oil CompanyInventors: Arthur K. Dunlop, Janis Vasilevskis